Back to Trades
Borgeson Blake
DirectorCIK 0001856094
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 9
- Companies
- 1
- Active
- 2025–2026
Borgeson Blake, Director, accounts for 10 disclosed filings worth $3.5M, all concentrated in RECURSION PHARMACEUTICALS, INC. (RXRX), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $3.5M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Sep 2 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $100.2K |
| Aug 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $97.5K |
| Jul 9 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $158.5K |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Grant | $0 |
| Jun 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $110.4K |
| May 7 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $105.6K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $93.0K |
| Feb 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $924.0K |
| Jan 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $959.2K |
| Dec 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $961.4K |
10 filings